Impaired Bile Acid Homeostasis in Children with Severe Acute Malnutrition

Ling Zhang1, Wieger Voskuijl2,3, Marialena Mouzaki4

  • 1Physiology and Experimental Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, Canada.

Plos One
|May 11, 2016
PubMed

Insights

Severe acute malnutrition (SAM) in children is linked to higher serum bile acids, even with reduced synthesis. This suggests altered bile acid metabolism may contribute to liver disease in SAM patients.

Area of Science:

  • Biochemistry
  • Pediatric Nutrition
  • Gastroenterology

Background:

  • Severe acute malnutrition (SAM) is a critical factor in childhood mortality.
  • SAM is frequently associated with hepatic steatosis (fatty liver disease).
  • Bile acids play vital roles in digestion, energy regulation, and immunity.

Purpose of the Study:

  • To investigate the association between SAM and clinically significant alterations in bile acid homeostasis.
  • To understand how bile acid metabolism changes in children with SAM.

Main Methods:

  • A discovery cohort (5 controls, 22 SAM patients) identified altered bile acid profiles.
  • A follow-up cohort (40 SAM patients) was studied on admission and after stabilization.
  • Bile acids, FGF19, and C4 were quantified in serum and feces; fecal calprotectin measured inflammation.

Main Results:

  • Children with SAM exhibited significantly higher serum bile acids (primarily glycine-conjugates) compared to controls.
  • Despite elevated serum levels, bile acid synthesis (indicated by C4) was reduced in SAM.
  • Increased fecal secondary bile acids and decreased conjugated bile acids suggested enhanced bacterial conversion in SAM patients.

Conclusions:

  • SAM is associated with elevated serum bile acid levels, paradoxical to reduced synthesis rates.
  • Increased deconjugation and bacterial conversion of bile acids in SAM may contribute to liver pathology.
  • Understanding these metabolic shifts is crucial for managing SAM and its complications.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
996
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.6K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
895